Related Experiment Video
Updated: Aug 7, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
[AIRE gene mutation in polyglandular syndrome type 1]
Ma M Martínez López1, I González Casado, R Alvarez Doforno
1Servicio de Endocrinología Pediátrica, Hospital Universitario La Paz, Melchior Fernández Almagro 16, 11B, 28029 Madrid, Spain. martinezlopezmm@hotmail.com
Anales De Pediatria (Barcelona, Spain : 2003)
|June 24, 2006
Summary
Autoimmune Polyglandular Syndrome Type 1 (APS-1) is linked to AIRE gene mutations. Genetic testing is crucial even with a single APS-1 symptom for early diagnosis.
Area of Science:
- Endocrinology
- Genetics
- Immunology
Background:
- Autoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare autosomal recessive disorder.
- Key features include chronic mucocutaneous candidiasis, autoimmune hypoparathyroidism, and primary adrenal insufficiency.
- APS-1 is associated with mutations in the AutoImmune Regulator (AIRE) gene on chromosome 21.
Observation:
- Two patients with suspected APS-1 were evaluated.
- Patient 1: 11-year-old girl with hypoparathyroidism, malabsorption, and autoimmune hepatitis.
- Patient 2: 17-year-old girl with autoimmune hepatitis, hypoparathyroidism, candidiasis, nail dystrophy, and bronchiolitis.
Findings:
- Genetic analysis in Patient 1 revealed a 13-base pair deletion in exon 8 of the AIRE gene.
- Genetic analysis in Patient 2 identified an AIRE gene polymorphism.
- These findings highlight the genetic basis of APS-1.
Implications:
- Suspecting APS-1 based on a single clinical criterion is sufficient to warrant genetic investigation.
- Further research is needed to explore the role of other genes in APS-1 pathogenesis.
- Early genetic diagnosis can facilitate timely management and potentially improve patient outcomes.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:39Mutations
Overview